Microsoft Word - VYVANSE.Product Monographdoc - TAAR1 agonists - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-03-02 15:52:19 Medicine Clinical medicine Neurochemistry Amphetamine Substituted amphetamines TAAR1 agonists Euphoriants Anorectics Lisdexamfetamine Dextroamphetamine Stimulant Anorexia		Microsoft Word - VYVANSE.Product Monographdoc Add to Reading List Source URL: www.shirecanada.com Download Document from Source Website File Size: 91,28 KB Share Document on Facebook

	VYVANSE® [Vī’ - văns] MEDICATION GUIDE (lisdexamfetamine dimesylate) CII Capsules What is the most important information I should know about DocID: 1tcsc - View Document
	prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT DocID: 1pBj0 - View Document
	prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of DocID: 1ou1z - View Document
	Microsoft Word - VYVANSE.Product Monographdoc DocID: 1m5V8 - View Document
	Patient Assistance Program Shire Pharma Canada ULC (“Shire”) developed the VYVANSE Patient Assistance Program (the “Program”) for Canadian patients requiring support by covering for t DocID: 1lpLs - View Document